Evidence map›Paper›PMID 15980339›Full record

ArticleAntimicrobial agents and chemotherapy2005

Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites.

Diana Villarreal, Philippe Nirdé, Mallorie Hide, Christian Barnabé, Michel Tibayrenc

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Coinfection by multipleMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  2. Fifteen Years after the Definition ofLife (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diana VillarrealGénétique et Evolution des Maladies Infectieuses G.E.M.I., UMR 2724 CNRS/IRD, UR 165 IRD, Centre de Recherche IRD, 911 avenue Agropolis, BP 64501, 34394 Montpellier Cedex 5, France.
Philippe Nirdé
Mallorie Hide
Christian Barnabé
Michel Tibayrenc

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed the differential gene expression among representative Trypanosoma cruzi stocks in relation to benznidazole exposures using a random differentially expressed sequences (RADES) technique. Studies were carried out with drug pressure both at the natural susceptibility level of the wild-type parasite (50% inhibitory concentration for the wild type) and at different resistance levels. The pattern of differential gene expression performed with resistant stocks was compared to the population structure of this parasite, established by random amplified polymorphic DNA analysis and multilocus enzyme electrophoresis. A RADES band polymorphism was observed, and over- or underexpression was linked to the resistance level of the stock. The analysis of RADES bands suggested that different products may be involved in benznidazole resistance mechanisms. No significant association was found between phylogenetic clustering and benznidazole susceptibility. Benznidazole resistance may involve several mechanisms, depending on the level of drug exposure.

Indexed as

Drug ResistanceGene Expression RegulationAnimalsElectrophoresisEnzymesGene Expression ProfilingHumansMolecular Sequence DataNitroimidazolesParasitic Sensitivity TestsPolymerase Chain ReactionProtozoan ProteinsRandom Amplified Polymorphic DNA TechniqueSequence Analysis, DNATrypanocidal AgentsTrypanosoma cruzibenzonidazoleEnzymesNitroimidazolesProtozoan ProteinsTrypanocidal Agents

Identifiers

PMID15980339
PMCPMC1168707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.